By analogy with semaglutide (where the STEP-4 withdrawal trial demonstrated substantial weight regain within 12 months of discontinuation), researchers should anticipate that weight regain is likely following cessation of any GLP-1 class compound, including retatrutide
Upholds peoples safety, health and the environment
Every liver peptide, evidence-graded
Suitable for vegans, diabetics, and those who cannot swallow capsules
Available safety data comes from animal research, limited clinical trials, and user documentation rather than the rigorous safety evaluation required for approved medications
PharmaLabGlobal Canada peptide pens are pre-loaded with the correct reconstitution of peptides, removing the need for manual measurement or mixing, therefore reducing the risk of error and ensuring correct dosing every time